Concepedia

Joseph Meserve

JM

16

Publications

804

Citations

13

H-Index

2015

Active since

Affiliations

University of California San Diego(Current)

New York University

Icahn School of Medicine at Mount Sinai

Dartmouth–Hitchcock Medical Center

Indiana University – Purdue University Indianapolis

Joseph Meserve is an author at University of California San Diego specializing in medicine, outcomes research, and gastroenterology.

ORCID

Top concepts

Publications per year

2015–2025

16

Publications

16

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 171 citations

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 140 citations · Full text

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace et al. · Clinical Gastroenterology and Hepatology · 2018 · 81 citations · Full text

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele et al. · Clinical Gastroenterology and Hepatology · 2020 · 76 citations · Full text

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

Eugenia Shmidt, Gursimran Kochhar, Justin Hartke et al. · Inflammatory Bowel Diseases · 2018 · 74 citations · Full text

Rows per page

1–5 of 16